Test Price
2,800 AED✅ Home Collection Available
TUFT1 Gene Tuftelin Deficiency Genetic Test (NGS) in Dubai
Executive Summary & Core Metrics
This DHA-licensed diagnostic assay offers definitive molecular analysis of the TUFT1 gene via next-generation sequencing (NGS) with Sanger confirmation. It provides a diagnostic sensitivity exceeding 99.9% for identifying pathogenic variants associated with amelogenesis imperfecta, enamel hypoplasia, and immune-mediated syndromes. All laboratory procedures adhere to ISO 9001:2015 quality standards.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Certified NGS & Sanger Validation
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM)
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in Result Interpretation
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
Test Overview & Methodology
The TUFT1 gene tuftelin deficiency NGS test is a comprehensive single-gene analysis that scans the entire TUFT1 coding region (exons and splice sites) for mutations linked to amelogenesis imperfecta, dermatological fragility, and immunological imbalances. This DHA-compliant next-generation sequencing assay provides definitive molecular diagnosis for patients presenting with unexplained enamel defects, recurrent skin infections, or suspected hereditary tuftelinopathy syndromes.
| Test Parameter | Our Test (ISO Lab) | Closest Alternative (Basic Lab) |
|---|---|---|
| Coverage | Full gene (exons & splice sites) | Hotspot panel (limited variants) |
| Methodology | NGS + Sanger confirmation | Sanger only (single exon) |
| Turnaround Time | 3–4 weeks | 6–8 weeks |
Physician Insight & Safety Protocols
“As a DHA-licensed Consultant Medical Geneticist, I emphasize that while this NGS test provides exceptional genetic clarity, clinical correlation with dental, dermatological, and immunological examinations remains essential. A negative result does not wholly rule out other tuftelin-related phenotypes, and I strongly advise that patients never adjust any ongoing medication without a comprehensive specialist review.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory and Medication Guidance
Medication Warning
Do not discontinue any prescribed medication, especially immunomodulators or corticosteroids, without consulting your physician. Always seek a comprehensive specialist review if you have any concerns about your current treatment.
Safety Exclusion Criteria & Emergency Red Flags
- Children under 18 years without legally authorised guardian consent as per UAE regulations.
- Inability to provide informed consent or severe needle phobia.
- Active cutaneous infection at the venipuncture site.
- Known severe coagulopathy (e.g., haemophilia) without haematologist clearance.
- Seek immediate medical care if you experience: persistent bleeding >10 minutes, fainting, rapid swelling, or signs of infection (redness, warmth, pus) at the draw site.
Patient FAQ & Clinical Guidance
1. What is the TUFT1 gene test and why is it performed?
The TUFT1 gene test uses next-generation sequencing to detect mutations causing tuftelin deficiency, linked to enamel defects and immune disorders. It confirms a molecular diagnosis for patients with clinical signs of amelogenesis imperfecta, recurrent infections, or suspicion of hereditary tuftelinopathy syndromes.
2. How long does it take to receive the TUFT1 genetic test results in the UAE?
Results are typically available within 3 to 4 weeks after sample collection at our DHA-licensed laboratory. For urgent cases, an expedited process may be available after physician consultation.
3. Does insurance cover the TUFT1 NGS test cost of 2800 AED?
We provide direct billing verification via WhatsApp to confirm if your UAE insurance policy covers the test. If not, self-payment or installment options are available. Contact +971 54 548 8731 for details.
UAE Regulatory & Data Privacy Adherence
This diagnostic service operates in full compliance with the following UAE legal frameworks:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – Ensuring all patient genetic data is handled with strict confidentiality and security.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – Governing the safe use of digital health records and telemedicine guidance.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – Providing the legal basis for informed consent, clinical safety, and patient rights during sample collection and result disclosure.
DNA Labs UAE is committed to the highest standards of data security and clinical excellence as an ISO 9001:2015 certified facility.
Clinical & Logistical Metadata
| Test Name | TUFT1 Gene Tuftelin Deficiency Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood (3–5 mL in EDTA tube) or saliva (Oragene kit) |
| Methodology Used | Next-Generation Sequencing (NGS) with Sanger confirmation |
| ICD-10-CM Code | K00.5 (Amelogenesis imperfecta) |
| LOINC Code | 21636-6 (Gene analysis) |
| DHA Facility License & Address | DHA Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians